Menu
Recruiting NCT03707691

Pitch Perception and Memory: Deficits and Training

No phase Interventional Cochlear Implants

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Listening tests. Pitch training protocol, visuo-spatial training protocol, EEG/MEG/MRI recordings..
Who it may be relevant to
Registry conditions: Cochlear Implants. Basic parameters: 5 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Pitch perception and memory are central in auditory cognition, in particular for sound source segregation and recognition, speech prosody and music processing. Here the investigator assess pitch perception and memory in hearing-impaired listeners wearing cochlear implant(s) and listeners with congenital amusia, both compared with control listeners. Behavioral, EEG, and MEG measures are collected in audio and audio-visual contexts to characterize pitch processing deficits, and test a pitch training program.

Interventions

  • Behavioral Listening tests. Pitch training protocol
    The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
  • Behavioral visuo-spatial training protocol
    The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
  • Behavioral EEG/MEG/MRI recordings.
    Listening tests. EEG/MEG/MRI recordings

Primary outcome measures

  • percentages of correct responses in listening tests [Time frame: during procedure]
  • reaction times in listening tests [Time frame: during procedure]
  • Event-Related Fields [Time frame: during procedure]
  • Oscillations [Time frame: during procedure]
Secondary outcome measures (6)
  • percentages of correct responses [Time frame: Day 0]
  • percentages of correct responses [Time frame: Day 0]
  • reaction times [Time frame: Day 0]
  • reaction times [Time frame: Day 0]
  • Event-Related Fields [Time frame: Day 0]
  • Oscillations [Time frame: Day 0]

Eligibility criteria

Inclusion criteria

For adult participants:

  • Aged between 18 and 90
  • Absence of neurological and psychiatric disorders
  • No major cognitive deficit, ability to understand and apply study instructions
  • Motivation to participate efficiently in the study
  • Written informed consent to participant in the study
  • Affiliated to social security
  • Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility

For underage participants:

  • Subject aged 5 years and over
  • Informed consent of parents or guardians for the participation of the child being studied
  • No neurological or psychiatric history
  • Without major cognitive impairment and ability to understand and apply setpoint.
  • Subject affiliated to a social security scheme
  • Motivation to participate effectively in the project

Exclusion criteria

For adult participants:

  • Age below 18 or above 90
  • Pregnant or breast-feeding woman

For underage participants:

\- Pregnant or nursing minors

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Basic science

Study locations

France · 1 center
  • Lyon Neuroscience Research Center — Bron

Identifiers

NCT: NCT03707691 · 69HCL18_0632 · 2018-A02670-55

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗